Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?
Gespeichert in:
| Veröffentlicht in: | Journal francais d'ophtalmologie 2020-06, Vol.43 (6), p.548 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | 548 |
| container_title | Journal francais d'ophtalmologie |
| container_volume | 43 |
| creator | Defoort-Dhellemmes, S |
| description | |
| doi_str_mv | 10.1016/j.jfo.2020.04.014 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_32451138</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32451138</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-86016302b71e83c53721689b7e38f44592af08884cbc481384e5bd2d896a9333</originalsourceid><addsrcrecordid>eNo1kMtKw0AYRgdBbKl9ADfyv0Di3JJMViL1Vih0U9yWyeRPMyXJxJmJ2Cfwta2oq291PjiHkBtGU0ZZfndMj41LOeU0pTKlTF6QOSsKkdCsLGZkGYKtKCtzXmQZuyIzwWXGmFBz8rUOEFv0CBoGxBoa58GNbWx117vOHazRHYTJf6DtOj0YBDv8EGB0QHANhNb5mET0PbSn2rvPk2k75937ZAeE6FHHHocI9eTtcDijNsBq-7Z-TFgJox5q7K25vyaXje4CLv92QXbPT7vVa7LZvqxXD5tk5IzFROVnXUF5VTBUwmSi4CxXZVWgUI2UWcl1Q5VS0lRGqrOhxKyqea3KXJdCiAW5_b0dp6rHej9622t_2v8HEd880GND</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Defoort-Dhellemmes, S</creator><creatorcontrib>Defoort-Dhellemmes, S</creatorcontrib><identifier>EISSN: 1773-0597</identifier><identifier>DOI: 10.1016/j.jfo.2020.04.014</identifier><identifier>PMID: 32451138</identifier><language>fre</language><publisher>France</publisher><subject>Antimalarials - administration & dosage ; Antimalarials - adverse effects ; Betacoronavirus ; Bone Density Conservation Agents - adverse effects ; Contraindications, Drug ; Coronavirus Infections - drug therapy ; Coronavirus Infections - epidemiology ; COVID-19 ; Humans ; Hydroxychloroquine - administration & dosage ; Hydroxychloroquine - adverse effects ; Obesity - complications ; Pandemics ; Pneumonia, Viral - drug therapy ; Pneumonia, Viral - epidemiology ; Renal Insufficiency - complications ; Retinal Diseases - chemically induced ; Risk Factors ; SARS-CoV-2 ; Tamoxifen - adverse effects</subject><ispartof>Journal francais d'ophtalmologie, 2020-06, Vol.43 (6), p.548</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32451138$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Defoort-Dhellemmes, S</creatorcontrib><title>Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?</title><title>Journal francais d'ophtalmologie</title><addtitle>J Fr Ophtalmol</addtitle><subject>Antimalarials - administration & dosage</subject><subject>Antimalarials - adverse effects</subject><subject>Betacoronavirus</subject><subject>Bone Density Conservation Agents - adverse effects</subject><subject>Contraindications, Drug</subject><subject>Coronavirus Infections - drug therapy</subject><subject>Coronavirus Infections - epidemiology</subject><subject>COVID-19</subject><subject>Humans</subject><subject>Hydroxychloroquine - administration & dosage</subject><subject>Hydroxychloroquine - adverse effects</subject><subject>Obesity - complications</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - drug therapy</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Renal Insufficiency - complications</subject><subject>Retinal Diseases - chemically induced</subject><subject>Risk Factors</subject><subject>SARS-CoV-2</subject><subject>Tamoxifen - adverse effects</subject><issn>1773-0597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMtKw0AYRgdBbKl9ADfyv0Di3JJMViL1Vih0U9yWyeRPMyXJxJmJ2Cfwta2oq291PjiHkBtGU0ZZfndMj41LOeU0pTKlTF6QOSsKkdCsLGZkGYKtKCtzXmQZuyIzwWXGmFBz8rUOEFv0CBoGxBoa58GNbWx117vOHazRHYTJf6DtOj0YBDv8EGB0QHANhNb5mET0PbSn2rvPk2k75937ZAeE6FHHHocI9eTtcDijNsBq-7Z-TFgJox5q7K25vyaXje4CLv92QXbPT7vVa7LZvqxXD5tk5IzFROVnXUF5VTBUwmSi4CxXZVWgUI2UWcl1Q5VS0lRGqrOhxKyqea3KXJdCiAW5_b0dp6rHej9622t_2v8HEd880GND</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Defoort-Dhellemmes, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>202006</creationdate><title>Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?</title><author>Defoort-Dhellemmes, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-86016302b71e83c53721689b7e38f44592af08884cbc481384e5bd2d896a9333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2020</creationdate><topic>Antimalarials - administration & dosage</topic><topic>Antimalarials - adverse effects</topic><topic>Betacoronavirus</topic><topic>Bone Density Conservation Agents - adverse effects</topic><topic>Contraindications, Drug</topic><topic>Coronavirus Infections - drug therapy</topic><topic>Coronavirus Infections - epidemiology</topic><topic>COVID-19</topic><topic>Humans</topic><topic>Hydroxychloroquine - administration & dosage</topic><topic>Hydroxychloroquine - adverse effects</topic><topic>Obesity - complications</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - drug therapy</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Renal Insufficiency - complications</topic><topic>Retinal Diseases - chemically induced</topic><topic>Risk Factors</topic><topic>SARS-CoV-2</topic><topic>Tamoxifen - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Defoort-Dhellemmes, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Journal francais d'ophtalmologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Defoort-Dhellemmes, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?</atitle><jtitle>Journal francais d'ophtalmologie</jtitle><addtitle>J Fr Ophtalmol</addtitle><date>2020-06</date><risdate>2020</risdate><volume>43</volume><issue>6</issue><spage>548</spage><pages>548-</pages><eissn>1773-0597</eissn><cop>France</cop><pmid>32451138</pmid><doi>10.1016/j.jfo.2020.04.014</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1773-0597 |
| ispartof | Journal francais d'ophtalmologie, 2020-06, Vol.43 (6), p.548 |
| issn | 1773-0597 |
| language | fre |
| recordid | cdi_pubmed_primary_32451138 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Antimalarials - administration & dosage Antimalarials - adverse effects Betacoronavirus Bone Density Conservation Agents - adverse effects Contraindications, Drug Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology COVID-19 Humans Hydroxychloroquine - administration & dosage Hydroxychloroquine - adverse effects Obesity - complications Pandemics Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Renal Insufficiency - complications Retinal Diseases - chemically induced Risk Factors SARS-CoV-2 Tamoxifen - adverse effects |
| title | Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A06%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20there%20a%20need%20for%20ophthalmological%20surveillance%20in%20the%20case%20of%20short-term%20hydroxychloroquine%20treatment%20during%20this%20COVID-19%20pandemic?&rft.jtitle=Journal%20francais%20d'ophtalmologie&rft.au=Defoort-Dhellemmes,%20S&rft.date=2020-06&rft.volume=43&rft.issue=6&rft.spage=548&rft.pages=548-&rft.eissn=1773-0597&rft_id=info:doi/10.1016/j.jfo.2020.04.014&rft_dat=%3Cpubmed%3E32451138%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32451138&rfr_iscdi=true |